Anesthetics Market Report 2025

The anesthetics market size has grown strongly in recent years. It will grow from $9.7 billion in 2024 to $10.27 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to historical industry shifts and market competition, historical environmental and ethical concerns, historical consumer preferences, historical disease outbreaks and pandemics, economic conditions and healthcare expenditure.

The anesthetics market size is expected to see steady growth in the next few years. It will grow to $12.36 billion in 2029 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to market demand variation, advancements in drug formulations, emerging markets and demographics, consumer preferences and awareness, competitive landscape and industry consolidation. Major trends in the forecast period include cost-effective anesthetic solutions, global health challenges, regulatory changes and safety measures, awareness and training, drug development and innovation.

The surge in the number of accidents stands out as a significant catalyst for the market, primarily attributed to the utilization of anesthetic drugs in surgical procedures necessitated by injuries and accidents. This increase is notably driven by a growing incidence of injuries and accidents that require surgical interventions. As per the World Health Organization's Global status report on road safety, road accidents reached 1.35 million, resulting in approximately 64 deaths per 100,000 vehicles.

The increasing number of surgeries is anticipated to drive the growth of the anesthesia market. Surgery, a medical discipline focused on treating injuries, illnesses, and various disorders through manual and instrumental techniques, is central to modern medicine. The growth of the anesthesia market is closely linked to the rising demand for surgical procedures, advancements in technology, and an emphasis on patient safety. As surgery continues to play a vital role in healthcare, the anesthesia market is expected to expand to meet the evolving requirements of healthcare providers and patients. For example, in March 2023, the British Association of Aesthetic Plastic Surgeons, a UK-based surgical organization, reported that 31,057 cosmetic surgeries were performed in the UK in 2022, reflecting a significant 102% increase from the previous year. Consequently, the rising number of surgeries is propelling the anesthesia market forward.

Leading companies in the anesthetics market are striving for innovation, introducing new products such as the train pulse oximeter to enhance their market profitability. The train pulse oximeter is specifically designed for use in low-resource settings, addressing challenges in remote or rural areas with limited access to medical equipment. In July 2022, Smile Train, Inc., a US-based nonprofit organization, launched the Lifebox-Smile Train pulse oximeter, a cost-effective device capable of monitoring patients' oxygen saturation during surgery, thereby enhancing anesthesia safety.

Leading companies in the anesthetics market are introducing innovative products, such as anesthesia delivery software, to improve and streamline the administration of anesthetic agents. Anesthesia delivery software includes specialized applications that support healthcare professionals in managing anesthetic agents during surgeries. For instance, in April 2022, GE Healthcare, a U.S.-based medical technology company, received FDA approval for its End-tidal Control (Et Control) software, the first software of its kind to semi-automate anesthesia delivery. This cutting-edge technology aims to enhance patient care and reduce greenhouse gas emissions during surgeries by autonomously maintaining target levels of anesthetic agents, potentially decreasing emissions by up to 44%. The software also boosts workflow efficiency by minimizing manual adjustments, thus reducing operating costs.

Major companies operating in the anesthetics market include Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Novartis International AG, AstraZeneca plc, Abbott Laboratories Inc., Boehringer Ingelheim International GmbH, Fresenius SE & Co. KGaA, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, B. Braun Melsungen AG, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Reddy's Laboratories Inc., Hikma Pharmaceuticals plc, Aspen Pharmacare Holdings Limited, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals Ltd., Piramal Enterprises Limited, Pacira BioSciences Inc., Maruishi Pharmaceuticals Co. Ltd., Claris Lifesciences Limited, Paion AG, Thera Wise, Hameln Pharmaceuticals Ltd., DLC Laboratories Inc., Verve Health Care Ltd.

North America was the largest region in the anesthetics market in 2024. Middle East is expected to be the fastest-growing region in the global anesthetics market during the forecast period. The regions covered in the anesthetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the anesthetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anesthetics market consists of sales of isoflurane, desflurane, sevoflurane, and nitrous oxide. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Anesthetics encompass substances that cause a local or widespread lack of sensation, including pain. Anesthesia achieves the suppression of reactions to sensory input by acting on the brain or peripheral nervous system. These drugs are administered to induce a sense of calm in patients through muscle relaxation, which often results in amnesia.

The main types of anesthetics are general anesthetics and local anesthetics. General anesthesia refers to a medically induced state of coma with a lack of defensive reflexes, typically caused by the injection of one or more general anesthetic drugs. Anesthetics are administered through various routes, including inhalation anaesthesia grugs, intravenous anaesthesia drugs, and topical anaesthesia drugs. They find applications in various medical procedures such as general surgeries, plastic surgeries, cosmetic surgeries, dental surgeries, and other medical interventions.

The anesthetics market research report is one of a series of new reports that provides anesthetics market statistics, including anesthetics industry global market size, regional shares, competitors with an anesthetics market share, detailed anesthetics market segments, market trends, and opportunities, and any further data you may need to thrive in the aesthetics industry. This anesthetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.